| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Harmony Biosciences Hldgs (NASDAQ:HRMY) through any online brokerage.
Other companies in Harmony Biosciences Hldgs’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Harmony Biosciences Hldgs has a consensus price target of $47.29.
The stock price for Harmony Biosciences Hldgs (NASDAQ: HRMY) is $38.4993 last updated September 30, 2026 at 6:08 PM EDT.
There are no upcoming dividends for Harmony Biosciences Hldgs.
Harmony Biosciences Hldgs does not have any upcoming earnings scheduled.
There is no upcoming split for Harmony Biosciences Hldgs.
Harmony Biosciences Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
